Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123056) titled 'Effect of Tegileridine on Postoperative Opioid-Related Adverse Reactions in Cesarean Section' on April 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangzhou Women and Children Medical Center Liuzhou Hospital
Condition:
Post-cesarean section pain
Intervention:
Group T:PCIA pump 2.5mg/100ml Tegileridine
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-04-27
Target Sample Size: Group T:47;Group S:47;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319352
Disclaimer: Curated by HT Syndication....